<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01044680</url>
  </required_header>
  <id_info>
    <org_study_id>06-10- CN-Roquette-01</org_study_id>
    <nct_id>NCT01044680</nct_id>
  </id_info>
  <brief_title>Effects of NUTRIOSE速FB Dietary Fiber Supplementation on Satiety, Body Fat, and Metabolic Syndrome in Overweight Adult Men</brief_title>
  <official_title>The Effects of NUTRIOSE速FB Dietary Fiber Supplementation on the Satiety, Body Fat Distribution, and Metabolic Syndrome Biomarkers of Overweight Adult Chinese Men 20-35 Years of Age.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roquette Freres</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sprim Advanced Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Roquette Freres</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to determine the effects of NUTRIOSE速 supplementation on body
      composition, satiety, and determinants of metabolic syndrome in overweight men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous trials of fiber supplementation have yielded equivocal results on body composition,
      satiety, and determinants of metabolic syndrome. This double-blind, randomized,
      placebo-controlled study was conducted to determine the effects of a proprietary soluble
      dextrin dietary fiber supplement (NUTRIOSE速) on these parameters in overweight males.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determinants of metabolic syndrome</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Overweight</condition>
  <condition>Metabolic Syndrome X</condition>
  <arm_group>
    <arm_group_label>Nutriose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>17 g NUTRIOSE consumed twice daily for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>17 g maltodextrin consumed twice daily for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>NUTRIOSE</intervention_name>
    <description>17 grams of NUTRIOSE consumed twice daily for 12 weeks</description>
    <arm_group_label>Nutriose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>17 g maltodextrin consumed twice daily for 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males 20-35 years

          -  body mass index of 24-28 kg/m2

          -  current employment and residence at one of three manufacturing plants with a
             controlled setting and with similar regimented working conditions 7 days a week

        Exclusion Criteria:

          -  current or recent dietary fiber supplementation

          -  use of lipid-lowering/hypertension medication

          -  current insulin injection use

          -  contraindication to fiber supplements, e.g. Crohn's disease

          -  allergy to wheat products

          -  recent or current antibiotic use
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shuguang Li, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tongji University Medical College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tongji University Medical College</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Pasman W, Wils D, Saniez MH, Kardinaal A. Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men. Eur J Clin Nutr. 2006 Aug;60(8):1024-34. Epub 2006 Feb 15.</citation>
    <PMID>16482066</PMID>
  </reference>
  <reference>
    <citation>van den Heuvel EG, Wils D, Pasman WJ, Saniez MH, Kardinaal AF. Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men. Eur J Nutr. 2005 Oct;44(7):445-51. Epub 2005 Feb 9.</citation>
    <PMID>15696402</PMID>
  </reference>
  <reference>
    <citation>van den Heuvel EG, Wils D, Pasman WJ, Bakker M, Saniez MH, Kardinaal AF. Short-term digestive tolerance of different doses of NUTRIOSE FB, a food dextrin, in adult men. Eur J Clin Nutr. 2004 Jul;58(7):1046-55.</citation>
    <PMID>15220947</PMID>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2010</study_first_submitted>
  <study_first_submitted_qc>January 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2010</study_first_posted>
  <last_update_submitted>January 7, 2010</last_update_submitted>
  <last_update_submitted_qc>January 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Laetitia Guerin-Deremaux</name_title>
    <organization>Roquette Freres</organization>
  </responsible_party>
  <keyword>fiber</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>overweight</keyword>
  <keyword>satiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

